Altimmune, Inc. (ALT) Financials

$7.25

south_east
-$0.01 (-0.14%)
Day's range
$7.22
Day's range
$7.57

ALT Income statement / Annual

Last year (2024), Altimmune, Inc.'s total revenue was $20,000.00, a decrease of 95.31% from the previous year. In 2024, Altimmune, Inc.'s net income was -$95.06 M. See Altimmune, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $20,000.00 $426,000.00 -$68,000.00 $4.41 M $8.19 M $5.80 M $10.33 M $41,503.00 $5.23 M $10.64 M
Cost of Revenue $0.00 $477,000.00 $68,000.00 $551,301.00 $33.51 M $17.07 M $18.46 M $18.41 M $7.22 M $5.06 M
Gross Profit $20,000.00 -$51,000.00 -$136,000.00 $3.86 M -$25.32 M -$11.26 M -$8.13 M -$18.36 M -$1.99 M $5.58 M
Gross Profit Ratio 1 -0.12 2 0.88 -3.09 -1.94 -0.79 -442.49 -0.38 0.52
Research and Development Expenses $82.23 M $65.80 M $70.54 M $74.54 M $49.77 M $17.77 M $18.46 M $18.41 M $4.84 M $5.13 M
General & Administrative Expenses $20.97 M $18.14 M $17.13 M $15.41 M $13.21 M $8.50 M $9.77 M $8.46 M $11.52 M $6.22 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $20.97 M $18.14 M $17.13 M $15.41 M $13.21 M $8.50 M $9.77 M $8.46 M $11.52 M $6.22 M
Other Expenses $0.00 $12.42 M -$32,000.00 -$373,868.00 $24,147.00 $15,139.00 $277,886.00 $5,670.00 $7,847.00 $8,137.00
Operating Expenses $103.19 M $96.36 M $87.67 M $89.95 M $62.98 M $26.27 M $28.22 M $16.17 M $16.49 M $11.50 M
Cost And Expenses $103.19 M $96.36 M $87.67 M $89.95 M $62.98 M $26.27 M $28.22 M $16.17 M $16.49 M $11.50 M
Interest Income $8.07 M $7.35 M $2.87 M $202,741.00 $322,514.00 $843,409.00 $226,597.00 $47,579.00 $1,047.00 $0.00
Interest Expense $9,000.00 $35,000.00 $8,000.00 $5,656.00 $9,421.00 $2,244.00 $297,090.00 $162,139.00 $168.15 B $54,581.00
Depreciation & Amortization $238,000.00 $477,000.00 $500,000.00 $551,301.00 $298,057.00 $387,321.00 $302,369.00 $139,019.00 $135,345.00 $141,604.00
EBITDA -$94.81 M -$87.94 M -$84.40 M -$96.53 M -$54.15 M -$20.19 M -$44.72 M -$51.76 M -$10.91 M -$3.18 M
EBITDA Ratio -4740.6 -206.42 1248.56 -19.43 -6.62 -3.31 -1.65 -387.26 -43.45 0.16
Operating Income Ratio -5158.6 -225.19 1290.29 -21.97 -6.69 -3.7 -4.15 -1254.01 -2.15 -0.32
Total Other Income/Expenses Net $8.11 M $7.48 M $2.83 M -$176,824.00 $337,240.00 $886,304.00 -$2.49 M -$18,506.00 $4,851.00 $3.21 M
Income Before Tax -$95.06 M -$88.45 M -$84.91 M -$97.09 M -$54.46 M -$20.58 M -$45.32 M -$52.06 M $205.02 M -$3.38 M
Income Before Tax Ratio -4752.95 -207.62 1248.68 -22.01 -6.65 -3.55 -4.39 -1254.46 39.2 -0.32
Income Tax Expense $0.00 $0.00 -$197,000.00 -$919,513.00 -$5.42 M -$58,500.00 -$6.15 M -$5.64 M $11.17 M $61,746.00
Net Income -$95.06 M -$88.45 M -$84.71 M -$96.17 M -$49.04 M -$20.52 M -$39.17 M -$46.43 M $193.85 M -$3.44 M
Net Income Ratio -4752.95 -207.62 1245.78 -21.81 -5.99 -3.54 -3.79 -1118.6 37.06 -0.32
EPS -1.34 -1.66 -1.81 -2.33 -1.91 -1.56 -13.98 -108.77 -49.8 -16.13
EPS Diluted -1.34 -1.66 -1.81 -2.33 -1.91 -1.56 -13.98 -108.77 -49.8 -16.13
Weighted Average Shares Out $71.00 M $53.25 M $46.93 M $41.28 M $25.64 M $13.12 M $2.80 M $426,832.00 $230,382.00 $213,284.00
Weighted Average Shares Out Diluted $71.00 M $53.25 M $46.93 M $41.28 M $25.64 M $13.12 M $2.80 M $426,832.00 $230,382.00 $213,284.00
Link